Mechanisms of interferon-alpha-induced depressive symptoms

Acta Neuropsychiatrica

Volumn 14, Issue 3, 2002, Pages 103-105

  Wichers, M C ^a   Maes, M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; CORTICOTROPIN; DESIPRAMINE; IMIPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE;

CORTICOTROPIN RELEASE; CYTOKINE PRODUCTION; DEPRESSION; EDITORIAL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOOD; NEGATIVE FEEDBACK; SEROTONINERGIC SYSTEM; SYMPTOM;

EID: 0036599524     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-5215.2002.140301.x     Document Type: Editorial

References (28)

1. Major depression induced by interferon-alpha in patients affected by hepatitis C virus
2. Psychiatric complications of long-term interferon alfa therapy
3. Psychiatric side effects during adjuvant therapy with interferon-alpha in patients with malignant melanoma. Clinical evaluation as well as diagnostic and therapeutic possibilities
4. Self and non-self in the brain
5. Permeability of the blood-brain and blood-spinal cord barriers to interferons
6. Human recombinant tumor necrosis factor and interferon affect the activity of neurons in the organum vasculosum laminae terminalis
7. The serotonin hypothesis of major depression
8. Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter
9. Effects of chronic administration of interferon alpha A/D on serotonergic receptors in rat brain
10. Effect of interferon-alpha on DOI-induced wetdog shakes in rats
11. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease
12. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma
13. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
14. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls
15. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients
16. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims
17. Clinical applications of the dexamethasone suppression test for endogenous depression
18. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy
19. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway
20. The role of the vagus nerve in cytokine-to-brain communication
21. Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10
22. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells
23. Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone
24. Repeated dexamethasone suppression test in depressed patients
25. Antidepressant drugs regulate corticotropin-releasing factor and tyrosine hydroxylase messenger RNAs in rat brain
26. Antidepressants restore hypothalamic-pituitary-adrenal feedback function in aged, cognitively-impaired rats
27. Paroxetine for the prevention of depression induced by high-dose interferon alfa
28. Five cases of interferon-alpha-induced depression treated with antidepressant therapy